OncoSec shares turn hot as microcap reports promising PhII data for an I/O one-two punch – Endpoints News

Endpoints News
Shares of tiny San Diego-based OncoSec Medical ignited Wednesday morning when the microcap biotech reported that its lead drug produced promising Phase II melanoma data. Researchers for the company say that a combination of their drug, …

…read more

Source:: MicroCap Stock News From Google News

Leave a Comment